Trevor F. Cox - Concepedia

Author

Trevor F. Cox

University of Liverpool ORCID

Also Known As

Cox, T, D. H. Palmer, Daniel Palmer, Douglas G. Altman, R Dunn, R. DUNN, R. Dunn, T Cox, T Dunn, T F Cox

189

Publications

8.8K

Citations

H-Index

126

Concepts

All Affiliations

University of Liverpool Cancer Research UK Newcastle University Royal Liverpool University Hospital University of Birmingham

About

Trevor F. Cox is an author at University of Liverpool specializing in medicine, engineering, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.4K
2	Engineering	12	13	471
3	Health Sciences	4	4	90
4	Business	1	1	12
5	Education	1	1	34

Trevor F. Cox

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Time-dependent ROC curve analysis in medical research: current methods and applications Adina Najwa Kamarudin, Trevor F. Cox, Ruwanthi Kolamunnage‐Dona BMC Medical Research Methodology	2017	820
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox, JAMA	2012	574
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study Juan W. Valle, Daniel H. Palmer, Richard Jackson, Journal of Clinical Oncology	2014	445
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial Gary Middleton, Paul Silcocks, Trevor F. Cox, The Lancet Oncology Pancreatic CancerMedicineImmunologyMetastatic Pancreatic CancerCancer Treatment	2014	370
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial William Greenhalf, Paula Ghaneh, John P. Neoptolemos, JNCI Journal of the National Cancer Institute	2013	332
The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers Philip J. Johnson, Sarah Pirrie, Trevor F. Cox, Cancer Epidemiology Biomarkers & Prevention	2013	319
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Clinical Gastroenterology and Hepatology HepatologyBalad-2 Serologic ModelsMedicineHistopathologyPathology	2016	311
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer Paola Martinelli, Enrique Carrillo de Santa Pau, Trevor F. Cox, Gut	2016	266
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma Paula Ghaneh, Jörg Kleeff, Christopher Halloran, Annals of Surgery	2017	247
Multidimensional Scaling Ian T. Jolliffe, Trevor F. Cox, Michael Cox Technometrics	1996	235

Page 1